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Abstract
Due to the complexity of the human body, most diseases present a high
inter-personal variability in the way they manifest, i.e. in their phenotype,
which has important clinical repercussions - as for instance the difficulty
in defining objective diagnostic rules. We here explore the hypothesis
that signs and symptoms used to define a disease should be understood in
terms of the dispersion (as opposed to the average) of physical observables.
To that end, we propose a computational framework, based on complex
networks theory, to map groups of subjects to a network structure, based
on their pairwise phenotypical similarity. We demonstrate that the re-
sulting structure can be used to improve the performance of classification
algorithms, especially in the case of a limited number of instances, both
with synthetic and real data sets. Beyond providing an alternative con-
ceptual understanding of diseases, the proposed framework could be of
special relevance in the growing field of personalised, or N -to-1, medicine.
Keywords: complex networks; personalised medicine; data analysis.
1 Introduction
This decade is witnessing important improvements in the way many diseases
and disorders are understood and treated, thanks to advancements spanning
from genetics to big data analysis; yet, a large share of them is still eluding our
comprehension. Such gap is partly the result of the complexity of translating
the symptoms and signs observed in a condition, to the real causes underpin-
ning it - an inverse problem equivalent to the “genotype to phenotype” one [1].
Still an additional important element has mostly been neglected: the way such
symptoms and signs are defined.
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A standard and prima facie good option entails detecting changes in the
expected value (that is, in the mean) of some variables - i.e. fever is considered a
sign of viral infection as the body temperature is usually higher in patients than
in control subjects. On the other hand, an alternative approach recognises that
the complexity of the human body implies that multiple elements may interact
in different ways depending on the characteristics of the patient. In other words,
if diseases are to be understood as network perturbations [2], such perturbations
can affect an individual node in different ways; and, as a result, the observable
that increases in one subject may decrease in a different person. According to
this approach to diseases, control subjects are such because they maintain the
standard homoeostasis and allostasis [3], and are hence homogeneous; and, on
the other hand, patients loose such homogeneity, and are thus characterised by
a higher variability. This inter-personal variability has recently been recognised
within the personalized medicine paradigm [4]; but its origins can be traced
back to Hippocrates himself [5]. In the light of this idea, a different approach
of understanding symptoms may be more appropriate, i.e. one in which the
average value of an observable is not as relevant as the corresponding variability.
Diseases could then be characterised by abnormal values, i.e. by an increase in
the standard deviation of the corresponding distribution, in sets of parameters
that may differ from individual to individual.
A simple example can help clarifying this concept. Suppose a set of control
subjects, all characterised by two physiological parameters a and b described
by a truncated normal distribution |N (0, 1)|. Most control subjects (actually
the 95.45% of them) will thus have values for a and b in the range [0, 2]. Let
us further suppose an additional population of people suffering from a disease,
whose effect is to unbalance the bodily homoeostasis; as a consequence, pa-
tients may be described by the distribution ap ∼ bp ∼ |N (0, 2)| - note the
increased standard deviation. What would a classical symptom analysis yield?
The answer would be a fuzzy definition: some patients will show no substantial
modification, being both a and b within the standard range; others will have
abnormal high values of a or of b; and a few of both a and b. The pathology
would thus be difficult to explain, and even more difficult to diagnose. The
alternative approach entails describing the disease in terms of the variability
observed in each group. Control subjects will thus be described as conforming
an homogeneous group, with E[|(a, b)|] = 2/√pi; patients a more heterogeneous
one, with E[|(ap, bp)|] = 4/
√
pi.
If the hypothesis here presented is true, such that diseases should be defined
in terms of higher variability, the expected result would be a high degree of
fuzziness in standard disease definitions, with expressions like “symptoms may
include” - as such symptom would appear for some patients, but not in all of
them, as depicted in the previous example. This is indeed found, for instance,
in the large heterogeneity observed in cancer: cells belonging to a same cancer
type, or even to the same patient, can display a strong phenotypic and func-
tional variability [6, 7]. Such effect is not exclusive of genetics, but appear in
other medical fields. Psychology and psychiatry yields several relevant exam-
ples: e.g. the obsessive-compulsive disorder, displaying an univocal definition
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and yet a wide range of phenotypes [8, 9]; similarly, depression [10]; attention-
deficit/hyperactivity disorder [11]; or borderline personality disorder [12]. As
the study of the (possibly) most complex system of all, this problem is also faced
in neuroscience, e.g. in Huntington’s [13], Parkinson’s [14], or Alzheimer’s [15]
diseases, all of them eluding a simple characterization. This has important clini-
cal repercussions, as it is difficult to provide practitioners with a set of objective
diagnostic rules, not partly relying on personal experience and judgement [16].
In this contribution we explore the idea of a paradigm shift in diseases char-
acterisation, based on moving from the average to the dispersion in the analysis
of signs. For this we propose a computational framework, based on complex
networks theory [17, 18], for the characterisations of groups of healthy subjects
and patients. It is based on the identification of the two sets of features that
optimise the homogeneity of respectively control subjects and patients; and on
the creation of a graph structure representing the pairwise distance between
individuals according to those sets. Besides yielding a compact representation
of the disease under study, we show how this framework can be successfully
used to improve the outcome of classification (i.e. diagnosis) tasks, especially
in situations with limited number of training instances. Results are shown for
synthetic and real data sets, the latter representing a wide range of biomedical
problems.
2 Methods
2.1 Convergence/divergence network creation
Based on the previous considerations, we here describe a computational method-
ology for creating a network structure in which instances belonging to previously
labelled groups are organised according to their internal affinity. Without loss
of generality, we here consider the case of two groups, respectively g1 and g2,
such that two networks naturally emerge: one (N1) maximising the coherence of
instances belonging to g1, and a second one (namely N2) maximising the coher-
ence of g2. For the sake of clarity, we here name the two structures respectively
as convergence and divergence networks - as, in the former, g1 instances con-
verge towards a common pattern, while in the latter they diverge from it. While
the proposed methodology can naturally be extended to additional groups and
networks, this example has been chosen due to its simplicity and relevance - as,
for instance, most biomedical classification problems deal with characterising
control subjects vs. patients.
In the simplest situation, each instance i would be characterised by a set of
features fi. A distance matrix D is then defined, whose element di,j corresponds
to the cosine distance between the two instances i and j:
di,j = DC(fi, fj) = 1− fi · fj||fi|| · ||fj || . (1)
Note that other distance metrics can be used, as will be discussed in Sec. 3.
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The internal coherence of each group is then estimated through the average of
all pairwise internal distances, i.e.:
c1 =
1
n1(n1 − 1)
∑
i∈g1,j∈g1,j 6=i
di,j , (2)
c2 =
1
n2(n2 − 1)
∑
i∈g2,j∈g2,j 6=i
di,j , (3)
n1 and n2 respectively representing the number of instances in groups g1
and g2.
While in this situation, i.e. using all features, instances of the two groups
may naturally be clustered, in general one is interested in finding the two sub-
sets of features, f c and fd, optimising the creation of the two networks. This
corresponds to the following maximisation problem:
argmax
fc
log
c2
c1
∣∣∣∣
fc
, (4)
argmax
fd
log
c1
c2
∣∣∣∣
fd
. (5)
Note that, in the first case, we are creating the convergence network, i.e. the
network in which the first set of instances are more homogeneous, and we thus
need to maximise c2/c1. On the other hand, the divergence network requires the
instances of the first group to be more heterogeneous than the second group,
i.e. the maximisation of c1/c2.
As depicted in Fig. 1, bottom part, the result of this first phase is a set
of two fully connected networks (cliques), respectively called convergence and
divergence. In both networks, nodes represent instances (irrespectively of their
group); and the weight of links between them the distance, in the selected
feature sub-space, between the corresponding instances. For the sake of clarity,
node colours in Fig. 1 depict the group affiliation, with each group laying in the
centre of the corresponding network.
2.2 From networks to classification
The previously obtained convergence / divergence networks have an intrinsic
value, as they can be used to represent the structures created by patients’ sim-
ilarity, and to identify the most relevant features in a data set. Nevertheless, if
the objective is to perform a classification task (e.g. a diagnosis), it is necessary
to transform the two networks into a set of features that can be understood by
a data mining algorithm - as directly training a classification algorithm with
the adjacency matrices is usually not efficient [19]. As the instances of the first
group are, by construction, more connected in the convergence network (as are
the instances of the second group in the divergence one), it seems natural to
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Figure 1: Graphical representation of the proposed methodology. The lower
inset depicts the process of creating the two convergence/divergence networks,
while the upper panel integrates them into a general classification task. See
main text for definitions and details.
use a centrality measure to describe each node. Specifically, we consider three
standard centralities: (i) the closeness centrality, defined as the inverse of the
average distance from the target node to any other node in the network [20];
(ii) the betweenness centrality, defined as proportional to the number of shortest
paths passing through the considered node [21]; and (iii) the eigenvector cen-
trality, a centrality measure that assess the importance of a node as a function
of the importance of its neighbours [22]. Note that, while all the three met-
rics assess the importance of nodes from a propagation perspective, they tackle
the problem from different points of view. Consequently, there is no a priori
way of predicting which one of them is more appropriate for the problem here
considered, and in what follows all three will be independently tested.
In the proposed framework, each instance of the original data set is finally
characterised by two features, i.e. its centrality in the convergence and diver-
gence networks, as depicted in Fig. 1. It is worth noting that this represents an
important reduction in the dimensionality of the problem, from |f | to 2. As is
well known in data mining [23], such drastic reduction in the number of features
yields important benefits, as a lower risk of overfitting, the possibility of working
with less instances, and an improved computational cost. If this usually comes
at the cost of loosing part of the encoded information, in subsequent sections we
will show how here this is not a concern, as enough information is encoded in
the networks to actually allow to improve the outcome of several classification
tasks.
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Instance class Features [0, nr) Features [nr, 2nr) Features [2nr, nt)
Class 1 N (0, 1) N (0, σ2) N (0, 1)
Class 2 N (0, σ2) N (0, 1) N (0, 1)
Table 1: Characteristics of the distributions from which synthetic data are
drawn. See main text for details.
3 Validation with synthetic data sets
In order to evaluate the added value yielded by the proposed framework in a
classification task, we here report results corresponding to an ensemble of syn-
thetic random data sets. These have been designed to be of maximal simplicity,
while enabling a sensitivity analysis of the algorithm with respect to their char-
acteristics.
First of all, we suppose a binary classification problem, e.g. aimed at discrim-
inating between healthy people and patients suffering from a given disease. A
total of ni instances are considered, equally distributed between the two classes
- in order to avoid classification biases. Each instance is then described by a
set of nt features, whose values are drawn from the normal distributions defined
in Tab. 1. These are designed to make some features have a higher variance
in patients; some a higher variance in control subjects; and finally, to make
some features irrelevant, thus only encoding noise. Three parameters control
the shape of the distributions, namely:
• σ2, increased standard deviation of the relevant features. This parameter
is used to simulate the increased heterogeneity in control subjects and
patients, hence σ2 > 1.
• nr, number of relevant features for each class, i.e. features whose hetero-
geneity is higher than for the other class.
• nt, total number of features in the data set. A given number of features,
namely nt − 2nr are completely random and do not depend on the in-
stance’s class. Note that nt ≥ 2nr.
These synthetic data sets have then been used to perform a classification
task, using Random Forests (RFs) [24] and a Leave-One-Out Cross Validation
(LOOCV) [25]. Results, in terms of the AUC of the classification [26] and as a
function of the four data set parameters, are shown in Fig. 2. The five curves
respectively depict:
• (Grey solid line) The score obtained by training the RFs using the raw
data.
• (Black solid line) The score obtained by training the RFs using the first 2nr
features of the raw data, i.e. the features that actually encode information.
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• (Blue/orange/green dashed lines) The score obtained by using the conver-
gence/divergence network centrality data - respectively closeness, alpha
and betweenness centralities.
Some interesting conclusions can be drawn. First of all, the proposed ap-
proach allows to get a classification score consistently higher than the one ob-
tained by only using the raw data. While this may be a consequence of using
a tailored data set, in Sec. 4 we will see how this also happens in several real
data sets. The convergence / divergence networks thus seem to be an efficient
way of synthesising biological information.
Secondly, it can be appreciated that all AUCs increase with the separation
(σ2), the number of instances (ni) and the number of relevant features (nr), as
more information is encoded in the data set. A different behaviour is observed
when the total number of features (nt) is increased, while keeping nr constant:
while the network performance is constant, the classification with all raw fea-
tures degrades. This suggests that the proposed methodology is not affected by
redundant and useless information, as the networks are inherently performing a
feature selection.
Additionally, convergence/divergence networks yield a relatively higher AUC
with low separations (σ2), low number of instances (ni) and high number of
relevant features (nr). As may be expected, RFs are not efficient in extracting
information that is sparsely encoded over a large number of features, when
differences between classes are minimal, and when few instances are available
for training. In all these cases, the networks help making explicit the information
that may not directly be accessible to the classification algorithm.
Finally, in all cases the alpha centrality is the network metric yielding the
best results, followed by the closeness and the betweenness centralities. Possibly
this is due to the alpha centrality’s higher capacity for accounting for the global
(macro-scale) structure of the network.
For the sake of completeness, three aspects of the analyses reported in Fig.
2 require further consideration: the classification algorithm, the shape of the
probability distribution underlying the data, and the way distances between
subjects are measures.
As for the first, i.e. the possibility of using different classification algorithms
beyond RF, Fig. 3 Left reports the average and the standard deviation of the
classification score, as obtained with the convergence/divergence networks (left
part) and the raw filtered data (right part) by several standard classification
algorithms: Random Forests (RF) [24], Decision Trees (DT) [27], Stochastic
Gradient Descent (SGD) with a hinge loss function [28], Support Vector Machine
(SVM) with radial kernels [29], and Gaussian Na¨ıve Bayes (GNB).
Differences between the five algorithms are small, the Random Forest being
the most efficient in both data sets. Nevertheless, two exceptions have to be
highlighted. Firstly, Support Vector Machines yield an extremely low classifica-
tion score using the convergence/divergence networks. Being this result a clear
outlier, it is most probably caused by some idiosyncrasies of the SVMs, than by
the method here proposed. Secondly, the Gaussian Na¨ıve Bayes algorithm yields
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Figure 2: Classification score in synthetic data sets, using the raw data
(black and grey solid lines), and the new features extracted from the conver-
gence/divergence networks (blue, orange and green dashed lines, respectively
for closeness, alpha and betweenness centralities). From left to right, top to
bottom, the four panels depict the score as a function of the increased variabil-
ity of data (σ2), the number of instances in the data set, the number of relevant
features (nr), and the total number of features (nt). Results correspond to the
average of 104 realisations.
good results in both cases, i.e. even with the raw data alone. This is neverthe-
less due to the way the problem is designed (i.e. by sampling instances from
normal distributions) and to the way this classification algorithm is constructed
(i.e. by fitting data to normal distributions of unknown mean and variance). In
other words, GNBs perfectly fit the hypothesis underlying the synthetic data,
and this results in an increase in the average classification score. Yet, when this
advantage is eliminated and instances are sampled from uniform distributions,
caeteris paribus, the classification score in raw data reduces from 0.631 to 0.583,
i.e. to the same level of the other algorithms.
Fig. 3 Right further reports the average classification score as obtained
when three additional probability distributions were used to create the raw
data: log-normal (µ = 0.0, σ = σ2), uniform and triangular (both in the range
[−σ2, σ2]). Each symbol also represents a different algorithm for calculating
the distance between instances: cosine, euclidean and manhattan. Results are
qualitatively similar, with the log-normal and uniform distributions yielding the
lowest classification scores - possibly due to the resulting distribution of outliers.
Similarly, the use of a different distance measure does not substantially impact
the output. The only significant exception arises for the combination uniform
8
Conv/Div networks Raw data (filtered)
Input features
0.4
0.6
0.8
Cl
as
sif
ica
tio
n 
sc
or
e
Classification model
RF
DT
SGD
SVM
GNB
Gaussian Log-normal Uniform Triangular
Data distribution
0.4
0.6
0.8
Cl
as
sif
ica
tio
n 
sc
or
e
Distance measure
Cosine
Euclidean
Manhattan
Figure 3: Additional sensitivity analyses. (Left) Classification score, as obtained
by five different classification algorithms with the convergence/divergence net-
works’ (left group of symbols) and the raw data (right group). (Right) Classifi-
cation score as a function of the underlying data probability distribution, and of
the considered distance function. In both panels, symbols and whiskers respec-
tively represent the average value and the corresponding standard deviation, as
obtained in 104 independent realisations. Parameters were fixed to ni = 50,
σ2 = 1.5, nr = 5 and nt = 15.
distribution / cosine distance, for which the algorithm fails to detect any pattern
in the data; this effect seems to be robust, and does not depend on the type of
classification model used.
4 Validation with real biomedical data sets
The validation of the proposed methodology has further been performed us-
ing a collection of real biomedical data sets, thus allowing to understand if
and when the convergence / divergence concept is of relevance in biology and
medicine. For that, nine data sets corresponding to the “Life science” area and
to a classification problem have been downloaded from the UCI Machine Learn-
ing Repository [30]. Inclusion criteria were a limited number of instances, thus
representing problems for which it is common to have small samples; and the
availability of numerical features. The choice of using a public data set has been
motivated by three considerations: first, the public availability of those data im-
plies that all results can be seamlessly reproduced (all data sets can be freely
downloaded from https://archive.ics.uci.edu/ml/index.php); second, the
website provides references to many research works in which those data have
been used, thus offering the possibility of comparing our results with relevant
literature; and third, it allows to test the proposed methodology on multiple
and diverse scenarios.
Table 2 lists the set of features used to create the convergence / divergence
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networks, along with references in which more details about the data sets can
be found. Fig. 4 depicts the evolution of the average classification score for
each data set, in terms of the resulting AUC, as a function of the number
of instances used in the training, when such classification is performed with a
Random Forest model [24] and a Leave-One-Out Cross Validation. Three scores
are compared: i) the AUC obtained with the raw data set (blue dashed line); ii)
the AUC for the classification performed using only the convergence / divergence
metric (black solid line); and iii) the AUC obtained when combining both sets of
instances (green dashed line). Note that the second metric quantifies how much
information about the original problem is retained, and thus how effective are
the convergence / divergence metrics in the dimensionality reduction; while
the third how complementary the two metrics are, with respect to the raw
features. Additional information for each data set, including histograms of the
selected features and the distribution of the convergence / divergence metrics,
are included in Supplemental Information.
It can be appreciated from Fig. 4 that the convergence / divergence metrics
yield heterogeneous classification performances, mainly depending on the data
set (and hence, on its characteristics) and on the number of instances.
First, it can happen that the classification score obtained with the conver-
gence / divergence networks is above what obtained with the raw features -
see the top row of Fig. 4. This advantage is smaller for high number of in-
stances, as standard classification algorithms are able to approximate the con-
vergence/divergence pattern. Nevertheless, even for large training groups, the
addition of the C/D metrics to the raw features improves the final classification.
Such scenario is clearly the most interesting one, as it implies that, on one hand,
the proposed methodology is able to extract the most important information
from the instance’s characteristics, thus enabling an important dimensionality
reduction. On the other hand, when very few instances are available, it is even
able to extract information usually not unveiled.
In the second scenario, the proposed methodology is able to extract informa-
tion that, while not especially useful in itself, can be used to improve a standard
classification task. This is represented by the second row of data sets in Fig. 4,
for which the orange dashed line (representing the combined data set) is always
above the blue one (raw features only). In these cases, the convergence / diver-
gence mechanism here hypothesised is not the only mechanism underlying the
pathological situation; yet, the networks help in making it more explicit, and
thus complement a more standard approach.
Finally, it is possible that the proposed approach is not relevant for the
problem under study: thus, both the C/D metrics, and their combination with
the raw features yield results below those of a standard classification model -
as can be observed in the last row of Fig. 4. This is not surprising, as not all
biomedical problems have to be explained by the mechanism here hypothesised.
For the sake of completeness, the results corresponding to the first three
data sets are analysed in more detail below, and compared with those available
in the literature.
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Figure 4: Evolution of the classification score (in terms of the AUC) as a func-
tion of the number of subjects in the training set, and for the nine UCI data
sets here considered - see main text and Tab. 2 for details. The three lines re-
spectively correspond to the score obtained with the raw features (blue dashed
line), with the convergence / divergence features (solid black), and with both
sets of features (dashed orange). Each point corresponds to the average AUC
obtained in 2000 random realisations.
Parkinson Speech Dataset.
This data set was designed to support speech pattern analyses of Parkinson’s
patients and control subjects, with the final aim of providing a simple diagnos-
tic tool. Multiple types of sounds, including sustained vowels, numbers, words
and short sentences, were recorded for each subject, for then extracting 26 am-
plitude, frequency and harmonicity based features [31]. Results, as depicted
in Fig. 4 top left, indicate that the proposed method is especially suitable for
analysing small sets of instances drawn from this data set. Interestingly, one of
the features, Shimmer (DDA), has previously yielded conflicting results, with
evidence in favour [40] and against [41] its relevance in diagnosing Parkinson’s.
Our results indicate that the average value is not relevant for the classification
(as the corresponding histograms for control subjects and patients are very sim-
ilar, see Supplemental Information); but is instead the intra-group variability,
when combined with that of the absolute jitter, that is relevant. While this
data set is quite similar to the Parkinson’s one [34], both in terms of scope and
feature extracted, the benefit yielded by the proposed approach in the latter
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Data set Convergence fea-
tures
Divergence features
Parkinson Speech [31]
Local jitter Absolute jitter
Median pitch Shimmer (dda)
Mice Protein Expression [32]
pCAMKII pELK
pNR2B pNR1
Coronary Artery Disease [33]
Triglyceride Creatine
Erithrocyte sedimenta-
tion rate
Triglyceride
Parkinson’s [34]
Max. fundamental fre-
quency
Avg. fundamental fre-
quency
DFA Shimmer (APQ5)
Anuran Calls [35]
MFCC2 MFCC1
MFCC4 MFCC4
Breast Tissue [36]
Phase angle Impedance distance
Slope of p.a. Length of s.c.
Diabetic Retinopathy [37]
MA1 Exudates3
Exudates1 Diameter
Indian Liver Patient [38]
Direct bilirubin Alamine Aminotrans-
ferase
Alkaline phosphotase Aspartate Aminotrans-
ferase
Breast Cancer Wisconsin [39]
Fractal dimension II Fractal dimension I
Concavity III Area II
Table 2: List of the nine considered UCI data sets. The second and third
columns respectively report the features used to create the convergence / diver-
gence networks, selected according to the procedure described in Sec. 2.1.
case is substantially smaller - see Fig. 4. We speculate that this may be caused
by the type of sounds recorded in each one of them - in the Parkinson’s case,
the only available information is that they were “sustained vowel phonations”
[42]. Finally, some additional results, as the evolution of the score as a function
of the number of trees included in the Random Forest, and as a function of the
number of features used to create the convergence / divergence networks, are
included in Supplemental Information.
Mice Protein Expression Dataset.
This second data set encodes the expression levels of 77 proteins, measured in the
cerebral cortex, for control and trisomic (Down syndrome’s [43]) mice [32]. Note
that the original division into he four groups, i.e. stimulated / not stimulated
to learn, and injected with saline / memantine, has here been disregarded. It
is worth highlighting that three of the four identified proteins (i.e. pCAMKII,
pELK and pNR1) were originally identified as relevant features for distinguish
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memantine-treated mice vs. control baseline[32]; and that levels of the two N-
methyl-D-aspartate receptor subunits pNR2B and pNR1 have been found to be
associated to improved learning following an electroacupuncture treatment [44].
Coronary Artery Disease Dataset.
The third test case, known in the UCI repository as the Z-Alizadeh Sani Data
Set, comprises information about control subjects and people diagnosed with a
coronary artery disease, the latter one presenting a narrowing of the coronary
artery of 50% or more. Features include demographic, symptom, ECG, and
laboratory results [33]. Two important results have to be highlighted. First of
all, none of the identified features were considered as important in the original
work - only the erithrocyte sedimentation rate (ESR) ranked 11 over 54 in
terms of importance in the final classification model. Indeed, if one observes
the value distributions of, e.g., creatine and triglyceride alone, these are very
similar for both patients and control subjects; yet their combination unveil a
higher variability in control subjects - see Supplemental Information. Secondly,
it is worth noting that triglyceride appears as a relevant feature both in the
creation of the convergence and of the divergence networks - a topic which is
further discussed in Supplemental Information.
5 Discussion and conclusions
In this contribution we presented a computational framework, based on complex
networks, that allows to change the way symptoms and signs are defined. In-
stead of identifying patterns involving differences in the mean of a given feature
between two (or more) groups, we here focus in changes in the variability. If
the latter aspect is usually disregarded by classical classification algorithms, we
here showed that it can be used to reconstruct a network structure, with nodes
representing subjects, and links the pairwise similarity between them; and that
such network structure can be used to improve the performance in a classifi-
cation task. This approach has firstly been tested with synthetic data sets, to
understand its behaviour under a wide range of controlled conditions; and sec-
ondly, following the hypothesis that the feature variability should especially be
relevant in biology and medicine, with real data sets representing a wide range
of biomedical problems. In some cases a significant increase in the classification
score has been observed, thus suggesting that the proposed mechanism is indeed
of relevance.
Both Figs. 2 and 4 indicate that the proposed methodology is especially well
suited for the analysis of small data sets - as similar results can be recovered by
standard algorithms only in the limit of a very high number of instances. This
may prima facie seem an important limitation, due to the increasing relevance
of “big data” in today’s scientific and clinical environments [45]. Nevertheless,
the opposed movement is also gaining momentum: due to increasing privacy
and security concerns, or to the need of stratifying instances to a much smaller
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scale, many applications have to be developed relying on very small data sets
[46, 47].
Additionally, both Fig. 4 and the discussion of Sec. 4 suggest that the
proposed framework can be used, in some cases, as a way to identify novel
biomarkers. Due to the way features are processed in the convergence / di-
vergence networks, some of them may be useless when considered alone, but
of relevance when interacting - as is the case of the features identified in the
Coronary Artery Disease Dataset.
Finally, it is worth noting that, while we here focused on classification tasks,
the conclusions’ validity goes well beyond the data mining field. When the
addition of a set of synthetic features (i.e. constructed on top of the available
data) results in an increase in the classification score, it can safely be assumed
that these new features are making explicit some information that was originally
encoded in the data, but in a form not suitable to be digested by the data mining
model. The increased score here observed confirms that the proposed approach
is describing the biomedical problems in a way that is more efficient (or explicit)
than what done by the raw data; or, in other words, that data are transformed
from the raw features’ to a more useful space.
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Supplemental Information
6 Methodology: supplemental analyses
6.1 Overlaps between the convergence and divergence sets
As seen in the analysis of the real biomedical data sets included in the main text,
it can happen that a same feature is recognised as simultaneously optimising the
convergence and divergence networks. While being something counterintuitive,
we are here going to show a possible mechanism explaining the appearance of
such situations.
First of all, let us consider a synthetic data set structured as illustrated in
the Tab. I of the main text. Specifically, and for the sake of simplicity, we will
consider a situation with the first two features being relevant for the first group,
two more being relevant for the second group, and six uncorrelated features -
i.e. nr = 2 and nt = 10. In an ideal situation, we would expect features 1
and 2 (respectively, 3 and 4) to be identified as relevant for the first group (for
the second group). Nevertheless, when the increase in the standard deviation of
the relevant features (denoted by 1 − σ2) is small enough, it may happen that
an irrelevant feature is selected instead, just due to random fluctuations. The
probability of such event to happen is plotted in Fig. 5 Left, as a function of
the standard deviation separation. Specifically, the black dashed line represents
the probability of an irrelevant feature to be selected at least in one set; and the
solid blue line the probability for an irrelevant feature to be selected to be part
of both sets at the same time. As may be expected, the probability of a single
appearance of an irrelevant feature is maximal when σ2 = 1, and decreases for
σ2 > 1; On the other hand, the probability of a double appearance is negligible.
As a second case, we consider the possibility of an irrelevant feature to
be partly correlated with one of the relevant features. For instance, let us
suppose the following case: f5 = f1 + N (0, 0.1σ2), N representing numbers
independently drawn from a normal distribution. The evolution of the two
probabilities, again as a function of the separation 1−σ2, is represented in Fig.
5 Centre. In this case, the probability of finding the irrelevant (now correlated)
feature in one of the two sets increases with the separation - in other words, the
feature is wrongly included in the set even for σ2  1. In order to understand
this, let us consider the case of two uncorrelated features f and g, each one
comprising values drawn from an uniform distribution U(−1, 1). Given two
instances, defined by a pair (f, g), the average distance between them is given
by the formula 215 (2 +
√
2 + 5 ln(1 +
√
2)), which is ≈ 1.04. If we now consider a
new feature h strongly correlated with f , and suppose that instances are defined
by pairs (f, h), the average distance between pairs of them is equivalent to the
average distance between two points located on a segment of length 2
√
2, which
yields 23
√
2 ≈ 0.94. In synthesis, the average distance between pairs of instances
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is on average smaller when considering features that are correlated; thus, the
uncorrelated feature is selected more often than what expected, as it increases
the coherence of the convergence set.
Finally, let us consider a third situation, in which one irrelevant feature is
correlated with two relevant features belonging to different groups. Specifically,
one can define f5 such that f5(i) = f1(i) +N (0, 0.1σ2) for instances i belonging
to the first group, and f5(i) = f3(i) + N (0, 0.1σ2) otherwise. In other words,
the feature f5, which was initially irrelevant, is now correlated with a relevant
feature of both groups of instances. This has two effects - see Fig. 5 Right.
First, it strongly increases the probability for f5 of appear in at least one group;
but it further make the probability of being part of both groups of features
non-negligible.
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Figure 5: Evolution of the probability of having an irrelevant feature selected
during the creation of the convergence / divergence networks, as a function of
the separation between the two groups. See the main text for details on the
interpretation.
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7 Validation with real biomedical data sets: de-
tails
This section includes detailed information on the convergence/divergence anal-
yses presented in Section Validation with real biomedical data sets of the main
paper. Specifically, for each one of the nine data sets considered, the following
images report:
• Convergence set and metrics. Information on the creation of the
convergence network, including (from left to right):
– Scatter plot of the two features for which the first set of instances is
more similar than the second one.
– Histograms of the values of the two features, divided according to
the instances’ group.
– Histogram of the final convergence metric.
• Divergence set and metrics. Information on the creation of the diver-
gence network, including (from left to right):
– Scatter plot of the two features for which the first set of instances is
more heterogeneous than the second one.
– Histograms of the values of the two features, divided according to
the instances’ group.
– Histogram of the final divergence metric.
• Final convergence network. For the sake of clarity, only the nodes
belonging to the giant component of the network are displayed, for a
maximum of 100 randomly chosen nodes (when available). Additionally,
low weight links have been pruned to keep an average degree of 5.
• Final divergence network. The same rules as for the representation of
the convergence network apply.
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8 Additional classification analyses
In this section we further report some results related with the classification task
executed on the Parkinson’s speech dataset.
Fig. 6, Left panel, reports the evolution of the classification score as a func-
tion of the number of instances used in the training, using the two centralities
extracted from the convergence / divergence networks. Additionally to the in-
formation reported in Fig. 4 of the main text, we report the score obtained with
Random Forests comprising 20, 100 and 200 trees. It can be appreciated that
the results are qualitatively similar, as, due to the limited number of features
used for training, there is little risk of overfitting.
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Figure 6: (Left) Evolution of the classification score in the Parkinson’s speech
dataset, as a function of the number of instances included in the training, and
for different numbers of trees trained in the Random Forest. (Right) Evolution
of the classification score, for the same data set, as a function of the number of
features selected to create the convergence / divergence networks.
Fig. 6, Right panel, depicts the classification score (with 30 instances for
training, and 50 trees) as a function of the number of features used in the cre-
ation of the convergence / divergence networks. Results suggest that including
more than two features does not substantially improve the efficacy of the task,
while it importantly increase the computational cost.
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